NextGen Biomed UK 2026

Biointron is excited to announce our participation in NextGen Biomed UK 2026, taking place March 24 - 25, 2026, at the QEII Centre in London, United Kingdom. Organized by Oxford Global, this flagship event brings together leaders from across the biologics R&D ecosystem to explore the latest innovations in discovery, development, and translation of next generation biotherapeutics.  

NextGen Biomed UK 2026 will unite scientists, biotech innovators, and industry experts to share insights across key areas including proteins, antibodies and ADCs, peptides, oligonucleotides, vaccines, and immunotherapy. The conference fosters high-impact discussions and collaboration to advance scientific understanding and accelerate the development of cutting-edge biologics that address unmet medical needs.  

As a leader in antibody discovery and biologics engineering, Biointron looks forward to engaging with peers, showcasing our expertise, and contributing to conversations that help drive the future of therapeutic innovation.  

We look forward to connecting with you in London this March at booth #61 to explore new opportunities, build partnerships, and help shape the next frontier in biomedicine at NextGen Biomed UK 2026. 

For more details about the event, please visit the NextGen Biomed UK 2026 website [https://oxfordglobal.com/nextgen-biomed/events/nextgen-biomed] 

Time: March 24 - 25, 2026 

Location: QEII Centre | London, United Kingdom 

Booth: #61